{"count": 24, "results": [{"_id": "36732827", "pmid": 36732827, "pmcid": "PMC9896807", "title": "Association of metformin exposure with low risks of frailty and adverse outcomes in patients with diabetes", "journal": "Eur J Med Res", "authors": ["Liu P", "Pan Y", "Song Y", "Zhou Y", "Zhang W", "Li X", "Li J", "Li Y", "Ma L"], "date": "2023-02-03T00:00:00Z", "doi": "10.1186/s40001-023-01017-6", "meta_date_publication": "2023 Feb 3", "meta_volume": "28", "meta_issue": "1", "meta_pages": "65", "score": 50287.855, "text_hl": "...Association between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@frailty@@@", "citations": {"NLM": "Liu P, Pan Y, Song Y, Zhou Y, Zhang W, Li X, Li J, Li Y, Ma L. Association of metformin exposure with low risks of frailty and adverse outcomes in patients with diabetes Eur J Med Res. 2023 Feb 3;28(1):65. PMID: 36732827", "BibTeX": "@article{36732827, title={Association of metformin exposure with low risks of frailty and adverse outcomes in patients with diabetes}, author={Liu P and Pan Y and Song Y and Zhou Y and Zhang W and Li X and Li J and Li Y and Ma L}, journal={Eur J Med Res}, volume={28}, number={1}, pages={65}}"}}, {"_id": "32596419", "pmid": 32596419, "pmcid": "PMC7297486", "title": "Is There an Association Between Metformin Exposure and Frailty?", "journal": "Gerontol Geriatr Med", "authors": ["Baskaran D", "Aparicio-Ugarriza R", "Ferri-Guerra J", "Milyani R", "Florez H", "Ruiz JG"], "date": "2020-06-15T00:00:00Z", "doi": "10.1177/2333721420924956", "meta_date_publication": "2020 Jan-Dec", "meta_volume": "6", "meta_issue": "", "meta_pages": "2333721420924956", "score": 50282.37, "text_hl": "Is There an Association Between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Exposure and @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@Frailty@@@?", "citations": {"NLM": "Baskaran D, Aparicio-Ugarriza R, Ferri-Guerra J, Milyani R, Florez H, Ruiz JG. Is There an Association Between Metformin Exposure and Frailty? Gerontol Geriatr Med. 2020 Jan-Dec;6():2333721420924956. PMID: 32596419", "BibTeX": "@article{32596419, title={Is There an Association Between Metformin Exposure and Frailty?}, author={Baskaran D and Aparicio-Ugarriza R and Ferri-Guerra J and Milyani R and Florez H and Ruiz JG}, journal={Gerontol Geriatr Med}, volume={6}, pages={2333721420924956}}"}}, {"_id": "40551233", "pmid": 40551233, "title": "Metformin reduces the risk of frailty: evidence from a Mendelian randomization study.", "journal": "Diabetol Metab Syndr", "authors": ["Chen T", "Liu YL", "Qiu HN", "Lin CY", "Wu F", "Li JB", "Lin JN"], "date": "2025-06-23T00:00:00Z", "doi": "10.1186/s13098-025-01825-2", "meta_date_publication": "2025 Jun 23", "meta_volume": "17", "meta_issue": "1", "meta_pages": "239", "score": 50271.54, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduces the risk of @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@frailty@@@: evidence from a Mendelian randomization study.", "citations": {"NLM": "Chen T, Liu YL, Qiu HN, Lin CY, Wu F, Li JB, Lin JN. Metformin reduces the risk of frailty: evidence from a Mendelian randomization study. Diabetol Metab Syndr. 2025 Jun 23;17(1):239. PMID: 40551233", "BibTeX": "@article{40551233, title={Metformin reduces the risk of frailty: evidence from a Mendelian randomization study.}, author={Chen T and Liu YL and Qiu HN and Lin CY and Wu F and Li JB and Lin JN}, journal={Diabetol Metab Syndr}, volume={17}, number={1}, pages={239}}"}}, {"_id": "38631189", "pmid": 38631189, "title": "Biomarkers of frailty.", "journal": "Mol Aspects Med", "authors": ["El Assar M", "Rodríguez-Sánchez I", "Álvarez-Bustos A", "Rodríguez-Mañas L"], "date": "2024-04-16T00:00:00Z", "doi": "10.1016/j.mam.2024.101271", "meta_date_publication": "2024 Apr 16", "meta_volume": "97", "meta_issue": "", "meta_pages": "101271", "score": 50263.996, "text_hl": "Intervention to treat @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@frailty@@@, including non-pharmacological ones, especially those involving physical exercise and nutrition, and pharmacological interventions, that include those targeting specific mechanisms such as myostatin inhibitors, @GENE_INS @GENE_3630 @@@insulin@@@ sensitizer @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and with special relevance for hormonal treatments are mentioned. ", "citations": {"NLM": "El Assar M, Rodríguez-Sánchez I, Álvarez-Bustos A, Rodríguez-Mañas L. Biomarkers of frailty. Mol Aspects Med. 2024 Apr 16;97():101271. PMID: 38631189", "BibTeX": "@article{38631189, title={Biomarkers of frailty.}, author={El Assar M and Rodríguez-Sánchez I and Álvarez-Bustos A and Rodríguez-Mañas L}, journal={Mol Aspects Med}, volume={97}, pages={101271}}"}}, {"_id": "36650694", "pmid": 36650694, "title": "Effects of hypoglycaemic therapy on frailty: a multi-dimensional perspective.", "journal": "Expert Rev Endocrinol Metab", "authors": ["Abdelhafiz AH"], "date": "2023-01-01T00:00:00Z", "doi": "10.1080/17446651.2023.2168644", "meta_date_publication": "2023 Jan", "meta_volume": "18", "meta_issue": "1", "meta_pages": "53-65", "score": 50262.1, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ seems to have a consistent and a positive effect on physical @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@frailty@@@. ", "citations": {"NLM": "Abdelhafiz AH. Effects of hypoglycaemic therapy on frailty: a multi-dimensional perspective. Expert Rev Endocrinol Metab. 2023 Jan;18(1):53-65. PMID: 36650694", "BibTeX": "@article{36650694, title={Effects of hypoglycaemic therapy on frailty: a multi-dimensional perspective.}, author={Abdelhafiz AH}, journal={Expert Rev Endocrinol Metab}, volume={18}, number={1}, pages={53-65}}"}}, {"_id": "33428709", "pmid": 33428709, "title": "Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study.", "journal": "J Gerontol A Biol Sci Med Sci", "authors": ["Hazuda HP", "Pan Q", "Florez H", "Luchsinger JA", "Crandall JP", "Venditti EM", "Golden SH", "Kriska AM", "Bray GA"], "date": "2021-04-30T00:00:00Z", "doi": "10.1093/gerona/glaa295", "meta_date_publication": "2021 Apr 30", "meta_volume": "76", "meta_issue": "5", "meta_pages": "929-936", "score": 50261.316, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ may be ineffective in reducing @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@frailty@@@ prevalence. ", "citations": {"NLM": "Hazuda HP, Pan Q, Florez H, Luchsinger JA, Crandall JP, Venditti EM, Golden SH, Kriska AM, Bray GA. Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study. J Gerontol A Biol Sci Med Sci. 2021 Apr 30;76(5):929-936. PMID: 33428709", "BibTeX": "@article{33428709, title={Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study.}, author={Hazuda HP and Pan Q and Florez H and Luchsinger JA and Crandall JP and Venditti EM and Golden SH and Kriska AM and Bray GA}, journal={J Gerontol A Biol Sci Med Sci}, volume={76}, number={5}, pages={929-936}}"}}, {"_id": "37497698", "pmid": 37497698, "title": "Metformin in type 2 diabetes: Evidence for its beneficial effects on frailty and sarcopenia.", "journal": "Curr Diabetes Rev", "authors": ["Pyrgioti EE", "Karakousis ND", "Georgakopoulos PN", "Papanas N"], "date": "2023-07-27T00:00:00Z", "doi": "10.2174/1573399820666230727101141", "meta_date_publication": "2023 Jul 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50261.316, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@: Evidence for its beneficial effects on @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@frailty@@@ and @DISEASE_Sarcopenia @DISEASE_MESH:D055948 @@@sarcopenia@@@.", "citations": {"NLM": "Pyrgioti EE, Karakousis ND, Georgakopoulos PN, Papanas N. Metformin in type 2 diabetes: Evidence for its beneficial effects on frailty and sarcopenia. Curr Diabetes Rev. 2023 Jul 27;():. PMID: 37497698", "BibTeX": "@article{37497698, title={Metformin in type 2 diabetes: Evidence for its beneficial effects on frailty and sarcopenia.}, author={Pyrgioti EE and Karakousis ND and Georgakopoulos PN and Papanas N}, journal={Curr Diabetes Rev}}"}}, {"_id": "30888034", "pmid": 30888034, "title": "Rationale and Study Design of a Randomized Clinical Trial of Metformin to Prevent Frailty in Older Adults With Prediabetes.", "journal": "J Gerontol A Biol Sci Med Sci", "authors": ["Espinoza SE", "Musi N", "Wang CP", "Michalek J", "Orsak B", "Romo T", "Powers B", "Conde A", "Moris M", "Bair-Kelps D", "Li Y", "Ganapathy V", "Jergensen TE", "Kelly LC", "Jiwani R"], "date": "2020-01-01T00:00:00Z", "doi": "10.1093/gerona/glz078", "meta_date_publication": "2020 Jan 1", "meta_volume": "75", "meta_issue": "1", "meta_pages": "102-109", "score": 50259.62, "text_hl": "Rationale and Study Design of a Randomized Clinical Trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ to Prevent @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@Frailty@@@ in Older Adults With @DISEASE_Prediabetic_State @DISEASE_MESH:D011236 @@@Prediabetes@@@.", "citations": {"NLM": "Espinoza SE, Musi N, Wang CP, Michalek J, Orsak B, Romo T, Powers B, Conde A, Moris M, Bair-Kelps D, Li Y, Ganapathy V, Jergensen TE, Kelly LC, Jiwani R. Rationale and Study Design of a Randomized Clinical Trial of Metformin to Prevent Frailty in Older Adults With Prediabetes. J Gerontol A Biol Sci Med Sci. 2020 Jan 1;75(1):102-109. PMID: 30888034", "BibTeX": "@article{30888034, title={Rationale and Study Design of a Randomized Clinical Trial of Metformin to Prevent Frailty in Older Adults With Prediabetes.}, author={Espinoza SE and Musi N and Wang CP and Michalek J and Orsak B and Romo T and Powers B and Conde A and Moris M and Bair-Kelps D and Li Y and Ganapathy V and Jergensen TE and Kelly LC and Jiwani R}, journal={J Gerontol A Biol Sci Med Sci}, volume={75}, number={1}, pages={102-109}}"}}, {"_id": "32304040", "pmid": 32304040, "title": "The Use of Metformin to Increase the Human Healthspan.", "journal": "Adv Exp Med Biol", "authors": ["Piskovatska V", "Storey KB", "Vaiserman AM", "Lushchak O"], "date": "2020-01-01T00:00:00Z", "doi": "10.1007/978-3-030-42667-5_13", "meta_date_publication": "2020", "meta_volume": "1260", "meta_issue": "", "meta_pages": "319-332", "score": 50258.906, "text_hl": "Growing amounts of evidence from clinical trials suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can effectively reduce the risk of many @DISEASE_Osteoporosis @DISEASE_MESH:D010024 @@@age-related diseases@@@ and conditions, including @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@cardiometabolic disorders@@@, @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@neurodegeneration@@@, @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@chronic inflammation@@@ and @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@frailty@@@. ", "citations": {"NLM": "Piskovatska V, Storey KB, Vaiserman AM, Lushchak O. The Use of Metformin to Increase the Human Healthspan. Adv Exp Med Biol. 2020;1260():319-332. PMID: 32304040", "BibTeX": "@article{32304040, title={The Use of Metformin to Increase the Human Healthspan.}, author={Piskovatska V and Storey KB and Vaiserman AM and Lushchak O}, journal={Adv Exp Med Biol}, volume={1260}, pages={319-332}}"}}, {"_id": "37085892", "pmid": 37085892, "pmcid": "PMC10122301", "title": "Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study", "journal": "Cardiovasc Diabetol", "authors": ["Mone P", "Martinelli G", "Lucariello A", "Leo AL", "Marro A", "De Gennaro S", "Marzocco S", "Moriello D", "Frullone S", "Cobellis L", "Santulli G"], "date": "2023-04-21T00:00:00Z", "doi": "10.1186/s12933-023-01817-4", "meta_date_publication": "2023 Apr 21", "meta_volume": "22", "meta_issue": "1", "meta_pages": "94", "score": 50257.723, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has been employed in post-menopausal @SPECIES_9606 @@@women@@@ and some reports have shown encouraging effects in terms of attenuated @<m>DISEASE_Frailty</m> @DISEASE_MESH:D000073496 @@@frailty@@@. ", "citations": {"NLM": "Mone P, Martinelli G, Lucariello A, Leo AL, Marro A, De Gennaro S, Marzocco S, Moriello D, Frullone S, Cobellis L, Santulli G. Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study Cardiovasc Diabetol. 2023 Apr 21;22(1):94. PMID: 37085892", "BibTeX": "@article{37085892, title={Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study}, author={Mone P and Martinelli G and Lucariello A and Leo AL and Marro A and De Gennaro S and Marzocco S and Moriello D and Frullone S and Cobellis L and Santulli G}, journal={Cardiovasc Diabetol}, volume={22}, number={1}, pages={94}}"}}]}